65219-818-13 : NDC 2026 Code

65219-818-13 : Nicardipine Hydrochloride ( Nicardipine Hydrochloride )

Additionally :

You can get information about “65219-818-13” NDC code in 65219-818-13 in HTML format

HTML | 65219-818-13 in TXT (Plain Text) format

TXT | 65219-818-13 in PDF (Portable Document Format)

PDF | 65219-818-13 in XML format

XML formats.

NDC Code : 65219-818-13 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "65219-818-13",
    "PackageDescription": "10 VIAL, GLASS in 1 CARTON (65219-818-13)  / 10 mL in 1 VIAL, GLASS (65219-818-03) ",
    "NDC11Code": "65219-0818-13",
    "ProductNDC": "65219-818",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Nicardipine Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Nicardipine Hydrochloride",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20240911",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA217548",
    "LabelerName": "Fresenius Kabi USA, LLC",
    "SubstanceName": "NICARDIPINE HYDROCHLORIDE",
    "StrengthNumber": "25",
    "StrengthUnit": "mg/10mL",
    "Pharm_Classes": "Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-19",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251117",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}